| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/06/2008 | US20080057136 An ionogenic surfactant, a metal chelating complex with an affinity for protons, solvent and carrier; preferably cetylpyridinium chloride, EDTA-zinc complex, and isopropanol; fungicides for oral, topical or intravenous administration; dandruff, acne, dermatitis |
| 03/06/2008 | US20080056996 Photodynamic therapy for the treatment of hair loss |
| 03/06/2008 | DE202007014575U1 Verwendung von Alaun Using alum |
| 03/06/2008 | DE102006041486A1 Cosmetic and dermatological composition comprises olive oil, yellow petroleum jelly, royal jelly and jerusalem artichoke distillate |
| 03/06/2008 | CA2662163A1 Method of treatment of photodermatoses |
| 03/06/2008 | CA2662038A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 03/06/2008 | CA2661494A1 Use of c7 sugars in prevention and treatment of mycoses |
| 03/06/2008 | CA2660175A1 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1894936A1 Organosilyl-Benzo-triazole derivatives, processes for their production and their use as UV protecting agents |
| 03/05/2008 | EP1894911A1 Vitamin d-like compound |
| 03/05/2008 | EP1893207A1 Use of substituted piperazine derivatives and morpholine derivatives |
| 03/05/2008 | EP1893191A1 Medicinal acidic cannabinoids |
| 03/05/2008 | EP1893173A1 Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds |
| 03/05/2008 | EP1893159A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN201030063Y Antiperspirant plaster |
| 03/05/2008 | CN101137658A Antipruritic agent for pruritus caused by multiple sclerosis |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 03/05/2008 | CN101137344A Hair cosmetic |
| 03/05/2008 | CN101134724A 1'-acetoxy chavicol acetate |
| 03/05/2008 | CN101134108A Desonide cyclodextrin clathrate compound and method for preparing the same |
| 03/05/2008 | CN101134097A Tincture for treating frostbite and chilblain |
| 03/05/2008 | CN101134096A White fleece-flower root tincture for improving hair growth |
| 03/05/2008 | CN101134094A Liniment for treating skin pruritus, eczema and scaly tetter |
| 03/05/2008 | CN101134072A Health products for dispelling acne |
| 03/05/2008 | CN101134053A Pharmaceutical composition capable of treating scald |
| 03/05/2008 | CN101134044A Composition based on salts of hyaluronic acid for treating epithelial lesions |
| 03/05/2008 | CN101134042A Notoginsenoside pharmaceutical composition and method for preparing the same and use thereof |
| 03/05/2008 | CN101134028A Artinoid ethyltester capsule |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372572C Recombinant plasmid with human thymosin Beta-4gene |
| 03/05/2008 | CN100372569C Dendrimer-photosensitizer complexes for medical applications |
| 03/05/2008 | CN100372562C Bedsore ointment and its preparation process |
| 03/05/2008 | CN100372550C Traditional Chinese medicine contg. three kinds of herb medicines, and its prepration method |
| 03/05/2008 | CN100372527C Composition for external use |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/01/2008 | CA2595839A1 Composition based on salts of hyaluronic acid for treating epithelial lesions |
| 02/28/2008 | WO2008024893A2 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 02/28/2008 | WO2008024390A2 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 02/28/2008 | WO2008024305A2 Bis (thiohydrazide amides) for treating melanoma |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008023998A1 N-acylethanolamines as wound healing agents |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023796A1 Proteoglycan production accelerator |
| 02/28/2008 | WO2008023455A1 Tyrosinase inhibitor |
| 02/28/2008 | WO2008023425A1 Composition for amelioration of skin condition |
| 02/28/2008 | WO2008023003A1 Drug combinations for treating airway diseases |
| 02/28/2008 | WO2008022784A2 Long-lasting absorption of flavonoids |
| 02/28/2008 | WO2008022484A2 Combinations of 5-ht3 receptor antagonists for topical treatment of disorders of skin |
| 02/28/2008 | US20080051408 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051351 Substances, Compositions, and Methods for Treating Alopecia |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051325 Oligopeptide |
| 02/28/2008 | US20080050458 Lupin Total Extract Consisting of a Lupin Sugar Extract and a Lupin Peptide Extract, Method for The Production and Use Thereof |
| 02/28/2008 | US20080050452 Metal-containing formulations and methods of use |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050404 Pressure Sore Treatment |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050346 Elastin producing fibroblast formulations and methods of using the same |
| 02/28/2008 | US20080050318 Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | US20080048052 Spray Nozzle Apparatus and Method of Use |
| 02/28/2008 | DE202004021418U1 Kosmetische oder dermatologische Zubereitung enthaltend nicht molekular gebundenen freien Sauerstoff Cosmetic or dermatological composition containing non-molecularly bonded free oxygen |
| 02/28/2008 | CA2661553A1 Method of treating or preventing oxidative stress-related disease |
| 02/28/2008 | CA2661496A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/28/2008 | CA2661430A1 Long-lasting absorption of flavonoids |
| 02/28/2008 | CA2661017A1 Organic compounds |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | CA2648521A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892293A1 Transcription factor decoy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891967A1 Long-lasting absorption of flavonoids |
| 02/27/2008 | EP1891960A1 Pharmaceutical formula for treating skin disease |
| 02/27/2008 | EP1891945A1 Treatment and prevention of excessive scarring |
| 02/27/2008 | EP1891944A1 Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases |
| 02/27/2008 | EP1891924A1 Composition for protection of body surface |
| 02/27/2008 | EP1891228A2 Hdac regulation assays, compounds and therapeutic compositions |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891111A1 Il-31 monoclonal antibodies and methods of use |
| 02/27/2008 | EP1891050A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 02/27/2008 | EP1891008A1 Oxindoles as kinase inhibitors |
| 02/27/2008 | EP1890704A1 Regeneration of vaginal tissue with non-systemic vaginal administration of estrogen |
| 02/27/2008 | EP1890692A1 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields |
| 02/27/2008 | EP1890672A1 Use of chromone derivatives |
| 02/27/2008 | EP1890671A1 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1506958B1 Process for producing shogaol and intermediates for the synthesis thereof |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1450867B1 Sterilizing tunnel for pharmaceutical containers |
| 02/27/2008 | EP1334731B1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |